{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T04:01:18Z","timestamp":1780286478079,"version":"3.54.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["201620"],"award-info":[{"award-number":["201620"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["201620"],"award-info":[{"award-number":["201620"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["201620"],"award-info":[{"award-number":["201620"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["201620"],"award-info":[{"award-number":["201620"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["201620"],"award-info":[{"award-number":["201620"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genome Med"],"DOI":"10.1186\/s13073-026-01640-y","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T07:24:44Z","timestamp":1776497084000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Developing a germline prostate cancer risk test incorporating rare and common variants, to inform clinical decisions: a route to precision oncology"],"prefix":"10.1186","volume":"18","author":[{"given":"Sarah","family":"Wakerell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Questa","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Merson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reshma","family":"Rageevakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark N","family":"Brook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tokhir","family":"Dadaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth C","family":"Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Pope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shameela","family":"Cousins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"McHugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Britt","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terri P","family":"McVeigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth K","family":"Bancroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalind A","family":"Eeles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsofia","family":"Kote-Jarai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,18]]},"reference":[{"issue":"3","key":"1640_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"10437","key":"1640_CR2","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/S0140-6736(24)00651-2","volume":"403","author":"ND James","year":"2024","unstructured":"James ND, Tannock I, N\u2019Dow J, Feng F, Gillessen S, Ali SA, et al. The Lancet Commission on prostate cancer: planning for the surge in cases. Lancet. 2024;403(10437):1683\u2013722.","journal-title":"Lancet"},{"issue":"11","key":"1640_CR3","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1158\/1055-9965.EPI-13-0568","volume":"23","author":"JB Hjelmborg","year":"2014","unstructured":"Hjelmborg JB, Scheike T, Holst K, Skytthe A, Penney KL, Graff RE, et al. The heritability of prostate cancer in the Nordic Twin Study of Cancer. Cancer Epidemiol Biomarkers Prev. 2014;23(11):2303\u201310.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"11","key":"1640_CR4","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1001\/jamaoncol.2023.3482","volume":"9","author":"BF Darst","year":"2023","unstructured":"Darst BF, Saunders E, Dadaev T, Sheng X, Wan P, Pooler L, et al. Germline Sequencing Analysis to Inform Clinical Gene Panel Testing for Aggressive Prostate Cancer. JAMA Oncol. 2023;9(11):1514\u201324.","journal-title":"JAMA Oncol"},{"issue":"2","key":"1640_CR5","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.euo.2024.02.003","volume":"7","author":"EJ Saunders","year":"2024","unstructured":"Saunders EJ, Dadaev T, Brook MN, Wakerell S, Govindasami K, Rageevakumar R, et al. Identification of Genes with Rare Loss of Function Variants Associated with Aggressive Prostate Cancer and Survival. Eur Urol Oncol. 2024;7(2):248\u201357.","journal-title":"Eur Urol Oncol"},{"issue":"6","key":"1640_CR6","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.3390\/cancers15061849","volume":"15","author":"S Tisseverasinghe","year":"2023","unstructured":"Tisseverasinghe S, Bahoric B, Anidjar M, Probst S, Niazi T. Advances in PARP Inhibitors for Prostate Cancer. Cancers (Basel). 2023;15(6):1849.","journal-title":"Cancers (Basel)"},{"issue":"12","key":"1640_CR7","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1038\/s41588-023-01534-4","volume":"55","author":"A Wang","year":"2023","unstructured":"Wang A, Shen J, Rodriguez AA, Saunders EJ, Chen F, Janivara R, et al. Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants. Nat Genet. 2023;55(12):2065\u201374.","journal-title":"Nat Genet"},{"key":"1640_CR8","unstructured":"Labcorp. Invitae Hereditary Prostate Cancer Panel. Available from: https:\/\/www.invitae.com\/us\/providers\/test-catalog\/test-01362. [Accessed: 12 Jun 2025]."},{"issue":"Database issue","key":"1640_CR9","first-page":"D925","volume":"41","author":"WS Rubinstein","year":"2013","unstructured":"Rubinstein WS, Maglott DR, Lee JM, Kattman BL, Malheiro AJ, Ovetsky M, et al. The NIH genetic testing registry: a new, centralized database of genetic tests to enable access to comprehensive information and improve transparency. Nucleic Acids Res. 2013;41(Database issue):D925\u201335.","journal-title":"Nucleic Acids Res"},{"key":"1640_CR10","unstructured":"PreventionGenetics. Prostate Cancer Panel. Available from: https:\/\/www.preventiongenetics.com\/testInfo?val=Prostate-Cancer-Panel. [Accessed: 12 Jun 2025]."},{"key":"1640_CR11","unstructured":"Fulgent Genetics. Prostate Cancer Comprehensive Panel. Available from: https:\/\/fulgentgenetics.com\/ComprehensiveCancer-Prostate. [Accessed: 12 Jun 2025]."},{"key":"1640_CR12","unstructured":"NHS England. 2025. National genomic testing directory, testing criteria for rare and inherited disease v8.1. Available from: https:\/\/www.england.nhs.uk\/publication\/national-genomic-test-directories\/. [Accessed: 24 Jul 2025]."},{"issue":"10","key":"1640_CR13","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1136\/jmg-2024-109845","volume":"61","author":"R Hall","year":"2024","unstructured":"Hall R, Bancroft E, Pashayan N, Kote-Jarai Z, Eeles RA. Genetics of prostate cancer: a review of latest evidence. J Med Genet. 2024;61(10):915\u201326.","journal-title":"J Med Genet"},{"issue":"4","key":"1640_CR14","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/s41391-023-00676-0","volume":"27","author":"H Tuffaha","year":"2024","unstructured":"Tuffaha H, Edmunds K, Fairbairn D, Roberts MJ, Chambers S, Smith DP, et al. Guidelines for genetic testing in prostate cancer: a scoping review. Prostate Cancer Prostatic Dis. 2024;27(4):594\u2013603.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"1640_CR15","unstructured":"NHS England. 2020. National Genomic Test Directory for cancer. Available from: https:\/\/webarchive.nationalarchives.gov.uk\/ukgwa\/20210401162848\/. [Accessed: 25 Jul 2025]."},{"key":"1640_CR16","unstructured":"Department of Health & Social Care. 2022. Genome UK: 2022 to 2025 implementation plan for England. Available from: https:\/\/www.gov.uk\/government\/publications\/genome-uk-2022-to-2025-implementation-plan-for-england\/genome-uk-2022-to-2025-implementation-plan-for-england#implementation-actions-2022-to-2025. [Accessed: 25 Jul 2025]."},{"key":"1640_CR17","unstructured":"NHS England. 2025. The National Genomic Test Directory. Available from: https:\/\/www.england.nhs.uk\/genomics\/the-national-genomic-test-directory\/. [Accessed: 25 Jul 2025]."},{"issue":"1","key":"1640_CR18","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41416-018-0141-7","volume":"119","author":"M Mijuskovic","year":"2018","unstructured":"Mijuskovic M, Saunders EJ, Leongamornlert DA, Wakerell S, Whitmore I, Dadaev T, et al. Rare germline variants in DNA repair genes and the angiogenesis pathway predispose prostate cancer patients to develop metastatic disease. Br J Cancer. 2018;119(1):96\u2013104.","journal-title":"Br J Cancer"},{"issue":"3","key":"1640_CR19","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.eururo.2019.01.050","volume":"76","author":"DA Leongamornlert","year":"2019","unstructured":"Leongamornlert DA, Saunders EJ, Wakerell S, Whitmore I, Dadaev T, Cieza-Borrella C, et al. Germline DNA Repair Gene Mutations in Young-onset Prostate Cancer Cases in the UK: Evidence for a More Extensive Genetic Panel. Eur Urol. 2019;76(3):329\u201337.","journal-title":"Eur Urol"},{"issue":"5","key":"1640_CR20","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1093\/jnci\/djaa132","volume":"113","author":"BF Darst","year":"2021","unstructured":"Darst BF, Dadaev T, Saunders E, Sheng X, Wan P, Pooler L, et al. Germline Sequencing DNA Repair Genes in 5545 Men With Aggressive and Nonaggressive Prostate Cancer. J Natl Cancer Inst. 2021;113(5):616\u201325.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"1640_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s44276-023-00024-8","volume":"2","author":"S Benafif","year":"2024","unstructured":"Benafif S, Jones AB, Merson S, Rageevakumar R, McGrowder E, Tyler M, et al. Germline sequencing in men with metastatic castration-resistant prostate cancer from the BARCODE2 study reveals a wide range of pathogenic variants in DNA repair genes. BJC Rep. 2024;2(1):15.","journal-title":"BJC Rep"},{"issue":"9","key":"1640_CR22","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20(9):1297\u2013303.","journal-title":"Genome Res"},{"issue":"5","key":"1640_CR23","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/ng.806","volume":"43","author":"MA DePristo","year":"2011","unstructured":"DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet. 2011;43(5):491\u20138.","journal-title":"Nat Genet"},{"key":"1640_CR24","doi-asserted-by":"crossref","unstructured":"Van der Auwera GA, Carneiro MO, Hartl C, Poplin R, Del Angel G, Levy-Moonshine A et al. From FastQ Data to High-Confidence Variant Calls: The Genome Analysis Toolkit Best Practices Pipeline. Curr Protoc Bioinformatics. 2013;43(1110):11.10.1\u201311.10.33.","DOI":"10.1002\/0471250953.bi1110s43"},{"key":"1640_CR25","doi-asserted-by":"crossref","unstructured":"Poplin R, Ruano-Rubio V, DePristo MA, Fennell TJ, Carneiro MO, Van der Auwera GA et al. Scaling accurate genetic variant discovery to tens of thousands of samples. bioRxiv. 2018:201178.","DOI":"10.1101\/201178"},{"key":"1640_CR26","unstructured":"Van der Auwera G, O\u2019Connor BD. 2020. Genomics in the Cloud: Using Docker, GATK, and WDL in Terra (1st Edition). O\u2019Reilly Media."},{"issue":"7","key":"1640_CR27","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/s41588-018-0142-8","volume":"50","author":"FR Schumacher","year":"2018","unstructured":"Schumacher FR, Al Olama AA, Berndt SI, Benlloch S, Ahmed M, Saunders EJ, et al. Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. Nat Genet. 2018;50(7):928\u201336.","journal-title":"Nat Genet"},{"issue":"1","key":"1640_CR28","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41588-020-00748-0","volume":"53","author":"DV Conti","year":"2021","unstructured":"Conti DV, Darst BF, Moss LC, Saunders EJ, Sheng X, Chou A, et al. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. Nat Genet. 2021;53(1):65\u201375.","journal-title":"Nat Genet"},{"issue":"3","key":"1640_CR29","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/bju.15535","volume":"129","author":"S Benafif","year":"2022","unstructured":"Benafif S, Ni Raghallaigh H, McGrowder E, Saunders EJ, Brook MN, Saya S, et al. The BARCODE1 Pilot: a feasibility study of using germline single nucleotide polymorphisms to target prostate cancer screening. BJU Int. 2022;129(3):325\u201336.","journal-title":"BJU Int"},{"issue":"1","key":"1640_CR30","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GR, Thormann A, et al. The Ensembl Variant Effect Predictor. Genome Biol. 2016;17(1):122.","journal-title":"Genome Biol"},{"issue":"D1","key":"1640_CR31","doi-asserted-by":"publisher","first-page":"D54","DOI":"10.1093\/nar\/gkab1058","volume":"50","author":"JM Rodriguez","year":"2022","unstructured":"Rodriguez JM, Pozo F, Cerd\u00e1n-V\u00e9lez D, Di Domenico T, V\u00e1zquez J, Tress ML. APPRIS: selecting functionally important isoforms. Nucleic Acids Res. 2022;50(D1):D54\u20139.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"1640_CR32","doi-asserted-by":"publisher","first-page":"D948","DOI":"10.1093\/nar\/gkae1071","volume":"53","author":"SC Dyer","year":"2025","unstructured":"Dyer SC, Austine-Orimoloye O, Azov AG, Barba M, Barnes I, Barrera-Enriquez VP, et al. Ensembl 2025. Nucleic Acids Res. 2025;53(D1):D948\u201357.","journal-title":"Nucleic Acids Res"},{"issue":"Database issue","key":"1640_CR33","doi-asserted-by":"publisher","first-page":"D980","DOI":"10.1093\/nar\/gkt1113","volume":"42","author":"MJ Landrum","year":"2014","unstructured":"Landrum MJ, Lee JM, Riley GR, Jang W, Rubinstein WS, Church DM, et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 2014;42(Database issue):D980\u20135.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"1640_CR34","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201324.","journal-title":"Genet Med"},{"key":"1640_CR35","unstructured":"Garrett A, Allen S, Loong L, Durkie M, Drummond J, Burghel GJ et al. CanVIG-UK Consensus Specification for Cancer Susceptibility Genes (CSGs) of ACGS Best Practice Guidelines for Variant Classification v2.19. 2024. Available from: https:\/\/www.cangene-canvaruk.org\/canvig-uk. [Accessed: 18 Sep 2024]."},{"key":"1640_CR36","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alf\u00f6ldi J, Wang Q, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581:434\u201343.","journal-title":"Nature"},{"issue":"4","key":"1640_CR37","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","volume":"99","author":"NM Ioannidis","year":"2016","unstructured":"Ioannidis NM, Rothstein JH, Pejaver V, Middha S, McDonnell SK, Baheti S, et al. REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants. Am J Hum Genet. 2016;99(4):877\u201385.","journal-title":"Am J Hum Genet"},{"issue":"3","key":"1640_CR38","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","volume":"176","author":"K Jaganathan","year":"2019","unstructured":"Jaganathan K, Kyriazopoulou Panagiotopoulou S, McRae JF, Darbandi SF, Knowles D, Li YI, et al. Predicting Splicing from Primary Sequence with Deep Learning. Cell. 2019;176(3):535\u2013e54824.","journal-title":"Cell"},{"key":"1640_CR39","unstructured":"UK Cancer Genetics Group. 2025. Exceptional variants\/gene-specific variant reporting. Available from: https:\/\/www.ukcgg.org\/information-education\/exceptional-variantsgene-specific-variant-reporting\/."},{"key":"1640_CR40","doi-asserted-by":"crossref","unstructured":"Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System. Am J Surg Pathol. 2016;40(2):244\u201352.","DOI":"10.1097\/PAS.0000000000000530"},{"key":"1640_CR41","unstructured":"National Comprehensive Cancer Network\u00ae. 2024. NCCN\u00aeClinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) for Prostate Cancer V.4.2024. Available from: NCCN.org. [Access granted to SM: 13 May 2025]. The NCCN makes no warranties of any kind whatsoever regarding their content, use or application, and disclaims any responsibility for their application or use in any way."},{"key":"1640_CR42","volume-title":"Stata Statistical Software: Release 19","author":"StataCorp","year":"2025","unstructured":"StataCorp. Stata Statistical Software: Release 19. College Station, TX: StataCorp LLC; 2025."},{"issue":"7993","key":"1640_CR43","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41586-023-06045-0","volume":"625","author":"S Chen","year":"2024","unstructured":"Chen S, Francioli LC, Goodrich JK, Collins RL, Kanai M, Wang Q, et al. A genomic mutational constraint map using variation in 76,156 human genomes. Nature. 2024;625(7993):92\u2013100.","journal-title":"Nature"},{"issue":"6","key":"1640_CR44","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.eururo.2021.09.029","volume":"81","author":"DJ Lee","year":"2022","unstructured":"Lee DJ, Hausler R, Le AN, Kelly G, Powers J, Ding J, et al. Association of Inherited Mutations in DNA Repair Genes with Localized Prostate Cancer. Eur Urol. 2022;81(6):559\u201367.","journal-title":"Eur Urol"},{"issue":"1","key":"1640_CR45","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1038\/s41467-025-57312-9","volume":"16","author":"T Gong","year":"2025","unstructured":"Gong T, Jiang J, Uthayopas K, Bornman MSR, Gheybi K, Stricker PD, et al. Rare pathogenic structural variants show potential to enhance prostate cancer germline testing for African men. Nat Commun. 2025;16(1):2400.","journal-title":"Nat Commun"},{"issue":"5","key":"1640_CR46","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.eururo.2021.12.023","volume":"81","author":"BF Darst","year":"2022","unstructured":"Darst BF, Hughley R, Pfennig A, Hazra U, Fan C, Wan P, et al. A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry. Eur Urol. 2022;81(5):458\u201362.","journal-title":"Eur Urol"},{"issue":"1","key":"1640_CR47","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1186\/s12885-025-15155-z","volume":"25","author":"J Rose-Dite-Modestine","year":"2025","unstructured":"Rose-Dite-Modestine J, Vallard A, Loger JS, Merle S, Noly L, Martin-Martinez A, et al. Prevalence and clinical significance of the rare HOXB13 X285K variant in a French Caribbean prostate cancer cohort. BMC Cancer. 2025;25(1):1703.","journal-title":"BMC Cancer"},{"issue":"5","key":"1640_CR48","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.ajhg.2024.04.002","volume":"111","author":"Y Wang","year":"2024","unstructured":"Wang Y, He Y, Shi Y, Qian DC, Gray KJ, Winn R, et al. Aspiring toward equitable benefits from genomic advances to individuals of ancestrally diverse backgrounds. Am J Hum Genet. 2024;111(5):809\u201324.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"1640_CR49","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s10038-023-01199-1","volume":"69","author":"BHL Harris","year":"2024","unstructured":"Harris BHL, McCabe C, Shafique H, Lammy S, Tookman L, Flanagan J, et al. Diversity of thought: public perceptions of genetic testing across ethnic groups in the UK. J Hum Genet. 2024;69(1):19\u201325.","journal-title":"J Hum Genet"},{"issue":"2","key":"1640_CR50","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/path.5829","volume":"256","author":"RAS Barreiro","year":"2022","unstructured":"Barreiro RAS, Sabbaga J, Rossi BM, Achatz MIW, Bettoni F, Camargo AA, et al. Monoallelic deleterious MUTYH germline variants as a driver for tumorigenesis. J Pathol. 2022;256(2):214\u201322.","journal-title":"J Pathol"},{"key":"1640_CR51","doi-asserted-by":"publisher","first-page":"e2300251","DOI":"10.1200\/PO.23.00251","volume":"8","author":"CJ Paller","year":"2024","unstructured":"Paller CJ, Tukachinsky H, Maertens A, Decker B, Sampson JR, Cheadle JP, et al. Pan-Cancer Interrogation of MUTYH Variants Reveals Biallelic Inactivation and Defective Base Excision Repair Across a Spectrum of Solid Tumors. JCO Precis Oncol. 2024;8:e2300251.","journal-title":"JCO Precis Oncol"},{"issue":"4","key":"1640_CR52","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1001\/jamaoncol.2018.6760","volume":"5","author":"P Nicolosi","year":"2019","unstructured":"Nicolosi P, Ledet E, Yang S, Michalski S, Freschi B, O\u2019Leary E, et al. Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines. JAMA Oncol. 2019;5(4):523\u20138.","journal-title":"JAMA Oncol"},{"issue":"2","key":"1640_CR53","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.eururo.2021.04.013","volume":"80","author":"BF Darst","year":"2021","unstructured":"Darst BF, Sheng X, Eeles RA, Kote-Jarai Z, Conti DV, Haiman CA. Combined Effect of a Polygenic Risk Score and Rare Genetic Variants on Prostate Cancer Risk. Eur Urol. 2021;80(2):134\u20138.","journal-title":"Eur Urol"},{"issue":"2","key":"1640_CR54","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1001\/jamaoncol.2024.5398","volume":"11","author":"LB Goss","year":"2025","unstructured":"Goss LB, Liu M, Zheng Y, Guo B, Conti DV, Haiman CA, et al. Polygenic Risk Score and Upgrading in Patients with Prostate Cancer Receiving Active Surveillance. JAMA Oncol. 2025;11(2):168\u201371.","journal-title":"JAMA Oncol"},{"issue":"14","key":"1640_CR55","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1056\/NEJMoa2407934","volume":"392","author":"JK McHugh","year":"2025","unstructured":"McHugh JK, Bancroft EK, Saunders E, Brook MN, McGrowder E, Wakerell S, et al. Assessment of a Polygenic Risk Score in Screening for Prostate Cancer. N Engl J Med. 2025;392(14):1406\u201317.","journal-title":"N Engl J Med"},{"key":"1640_CR56","doi-asserted-by":"publisher","first-page":"102259","DOI":"10.1016\/j.fsigen.2020.102259","volume":"46","author":"P Pfaffelhuber","year":"2020","unstructured":"Pfaffelhuber P, Grundner-Culemann F, Lipphardt V, Baumdicker F. How to choose sets of ancestry informative markers: A supervised feature selection approach. Forensic Sci Int Genet. 2020;46:102259.","journal-title":"Forensic Sci Int Genet"},{"issue":"5","key":"1640_CR57","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/ejhg.2015.187","volume":"24","author":"HC Santos","year":"2016","unstructured":"Santos HC, Horimoto AV, Tarazona-Santos E, Rodrigues-Soares F, Barreto ML, Horta BL, et al. A minimum set of ancestry informative markers for determining admixture proportions in a mixed American population: the Brazilian set. Eur J Hum Genet. 2016;24(5):725\u201331.","journal-title":"Eur J Hum Genet"}],"container-title":["Genome Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13073-026-01640-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-026-01640-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-026-01640-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T03:23:48Z","timestamp":1780284228000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13073-026-01640-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,18]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1640"],"URL":"https:\/\/doi.org\/10.1186\/s13073-026-01640-y","relation":{},"ISSN":["1756-994X"],"issn-type":[{"value":"1756-994X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,18]]},"assertion":[{"value":"29 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received ethical approval from the Research Ethics Committee (reference 18\/WM\/0316) and all study participants provided written consent upon joining the study. This research conformed with the Declaration of Helsinki ethical principles for medical research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Professor Rosalind Eeles has the following conflicts of interest to declare: Honoraria from GU-ASCO, Janssen, University of Chicago, Dana Farber Cancer Institute USA as a speaker. Educational honorarium from Bayer and Ipsen, member of external expert committee to Astra Zeneca UK and member of Active Surveillance Movember Committee. She is a member of the SAB of Our Future Health. She undertakes private practice as a sole trader at The Royal Marsden NHS Foundation Trust and 90 Sloane Street SW1\u2009\u00d7\u20099PQ and 280 Kings Road SW3 4NX, London, UK.Sarah Wakerell, Dan Burns and Zsofia Kote-Jarai are inventors on a recently filed GB priority patent application related to the methods described in this manuscript. At the time of publication, the patent application was owned by the ICR and not licensed or optioned to any organisation.The remaining authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"78"}}